Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01931852 · ClinicalTrials.gov registry record · NA

Cardiac Magnetic Resonance Imaging Strategy for the Management of Patients With Acute Chest Pain and Detectable to Elevated Troponin

A NA study, sponsored by Wake Forest University Health Sciences.

Completed
Registry status
NA
Development phase
312
Enrollment target

NCT01931852: Completed NA study, sponsored by Wake Forest University Health Sciences.

NCT01931852 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 312 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01931852, a NA study, has completed, sponsored by Wake Forest University Health Sciences.

COMPLETED
Registry status
NA
Development phase
312 participants
Enrollment target

Study Summary

The broad, long-term objective is to improve outcomes by optimizing healthcare delivery processes for patients with detectable to elevated serum troponin. This clinical trial involving emergency department (ED) patients with intermediate to high-risk chest pain and detectable to minimally elevated serum troponin within 6 hours of evaluation.

Primary Outcome

Test whether a CMR-guided strategy (versus invasive-based guideline-adherent strategy) reduces the composite of death, nonfatal MI, cardiac-related hospital readmission, and cardiac-related ED visits over time.

Interventions

  • PROCEDURE Cardiac MRI
  • OTHER ACC/AHA Guideline adherent care

Trial Details

FieldValue
Enrollment Target 312 participants
Start Date 2013-09
Est. Completion 2020-10-02
Phase NA
Wake Forest University Health Sciences

1,140 total trials

What the finished NCT01931852 record still lists

NCT01931852 is an interventional study that assigns participants to a tested intervention. The registered 312 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower).

The record links to 0 conditions, and to 2 interventions - of which Cardiac MRI is the first listed.

NCT01931852 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01931852 about?

NCT01931852 is a clinical study titled "Cardiac Magnetic Resonance Imaging Strategy for the Management of Patients With Acute Chest Pain and Detectable to Elevated Troponin". The broad, long-term objective is to improve outcomes by optimizing healthcare delivery processes for patients with detectable to elevated serum troponin. This clinical trial involving emergency department (ED) patients with intermediate to high-risk chest pain and detectable to minimally elevated s...

What is the current status of trial NCT01931852?

This trial is currently completed. It is a NA study. The enrollment target is 312 participants. The study started on 2013-09. Estimated completion is 2020-10-02.

What interventions are being tested in trial NCT01931852?

The interventions under investigation include: Cardiac MRI (PROCEDURE), ACC/AHA Guideline adherent care (OTHER).

Who is sponsoring clinical trial NCT01931852?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01931852's enrollment target sits among peer trials

312 323rd of 2000 higher than 1,678 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04984551 · 312 participants · Phase 2

    Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia

  • NCT04999904 · 312 participants · NA

    A Proprioceptive Training Program Using an Uneven Terrain Treadmill for Patients With Ankle Instability

  • NCT05220332 · 312 participants · NA

    Church-based Intervention to Improve Blood Pressure in African Americans

  • NCT05434234 · 312 participants · Phase 1

    A Study of YL201 in Patients With Advanced Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01931852, the US trial registry maintained by the National Library of Medicine. NCT01931852 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.